Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

High karyotypic complexity is an independent prognostic factor in patients with CLL treated with venetoclax combinations

Moritz Fürstenau, Yvonne J. Thus, Sandra Robrecht, Clemens H. M. Mellink, Anne-Marie van der Kevie-Kersemaekers, Julie Dubois, Julia von Tresckow, Michaela Patz, Michael Gregor, Patrick Thornton, Philipp B. Staber, Tamar Tadmor, Mark-David Levin, Caspar da Cunha-Bang, Christof Schneider, Christian Bjoern Poulsen, Thomas Illmer, Björn Schöttker, Ann Janssens, Ilse Christiansen, Thomas Nösslinger, Michael Baumann, Holger Hebart, Tobias Gaska, Josien C. Regelink, Ellen C. Dompeling, Vesa Lindström, Gunnar Juliusson, Anouk Widmer, Jeroen Goede, Neta Goldschmidt, Florian Simon, Nisha De Silva, Anna-Maria Fink, Kirsten Fischer, Clemens-Martin Wendtner, Matthias Ritgen, Monika Brüggemann, Eugen Tausch, Marcel Spaargaren, Eric Eldering, Stephan Stilgenbauer, Carsten U. Niemann, Michael Hallek, Barbara Eichhorst, Karl-Anton Kreuzer, Arnon P. Kater

Blood (2023) 142 (5): 446–459.

https://doi.org/10.1182/blood.2023019634

Published: 2023

Includes: Supplemental data

Journal Articles

High Karyotypic Complexity and Translocations Are Adverse Prognostic Features in Patients with Chronic Lymphocytic Leukemia without TP53 Aberrations Treated with Venetoclax-Based Time-Limited Combinations

Blood (2022) 140 (Supplement 1): 842–845.

https://doi.org/10.1182/blood-2022-164786

Published: 2022

Journal Articles

High efficacy of venetoclax plus obinutuzumab in patients with complex karyotype and chronic lymphocytic leukemia

Othman Al-Sawaf, Esther Lilienweiss, Jasmin Bahlo, Sandra Robrecht, Anna-Maria Fink, Michaela Patz, Maneesh Tandon, Yanwen Jiang, William Schary, Matthias Ritgen, Eugen Tausch, Stephan Stilgenbauer, Barbara Eichhorst, Kirsten Fischer, Michael Hallek, Karl-Anton Kreuzer

Blood (2020) 135 (11): 866–870.

https://doi.org/10.1182/blood.2019003451

Published: 2020

Includes: Supplemental data

Journal Articles

ROR-1 Is a Highly Discriminative Marker in Flow Cytometric Minimal Residual Disease (MRD) Detection in Chronic Lymphocytic Leukemia (CLL)

Michaela Patz, Barbara Pentok, Kathrin Cremer, Stefanie Linnartz, Esther Lilienweiss, Fanni Kleinert, Michael Hallek, MD, Karl-Anton Kreuzer

Blood (2016) 128 (22): 3197.

https://doi.org/10.1182/blood.V128.22.3197.3197

Published: 2016

Journal Articles

p38 MAPK Controls Sensitivity Towards BH3 Mimetics By Regulating Mcl-1 Expression of Chronic Lymphocytic Leukemia in Hypoxia and Acquired Resistance

Malte F Huelsemann, Michaela Patz, PhD, Laura Beckmann, Kerstin Brinkmann, Teresa Otto, Joachim Fandrey, MD, Hans Jiro Becker, Sebastian Theurich, MD, Michael S. von Bergwelt-Baildon, MD PhD, Christian P. Pallasch, MD, Réne P. Zahedi, Hamid Kashkar, PhD, Christian Reinhardt, MD, Michael Hallek, MD, Clemens-Martin Wendtner, MD, Lukas P. Frenzel, MD

Blood (2014) 124 (21): 1947.

https://doi.org/10.1182/blood.V124.21.1947.1947

Published: 2014

Journal Articles

Impact of Hypoxia As Novel Microenvironmental Factor On Drug Susceptibility of Primary CLL Cells

Malte Huelsemann, Lukas P. Frenzel, MD, Dunja Baatout, M.Sc., Julia Claasen, Sebastian Theurich, MD, Laurent Kintzelé, Hans Jiro Becker, Michaela Patz, PhD, Christian P. Pallasch, MD, Michael S. von Bergwelt-Baildon, MD, PhD, Michael Hallek, MD, Clemens-Martin Wendtner, MD

Blood (2012) 120 (21): 3918.

https://doi.org/10.1182/blood.V120.21.3918.3918

Published: 2012

Journal Articles

Novel Tyrosine Kinase Inhibitors Trigger Drug Sensitivity of Primary CLL Cells by Controlling Glucosylation of Ceramides

Janine Schwamb, MD, Valeska Feldhaus, M.Sc., Michael Baumann, MD, Michaela Patz, PhD, Susanne Brodesser, PhD, Reinhild Brinker, Julia Claasen, Christian P. Pallasch, MD, Michael Hallek, MD, Clemens-Martin Wendtner, MD, Lukas P. Frenzel, MD

Blood (2012) 120 (21): 3905.

https://doi.org/10.1182/blood.V120.21.3905.3905

Published: 2012

Journal Articles

B-cell receptor triggers drug sensitivity of primary CLL cells by controlling glucosylation of ceramides

Janine Schwamb, Valeska Feldhaus, Michael Baumann, Michaela Patz, Susanne Brodesser, Reinhild Brinker, Julia Claasen, Christian P. Pallasch, Michael Hallek, Clemens-Martin Wendtner, Lukas P. Frenzel

Blood (2012) 120 (19): 3978–3985.

https://doi.org/10.1182/blood-2012-05-431783

Published: 2012

Includes: Supplemental data

Journal Articles

B Cell Receptor Stimulation of CLL Cells Leads to Upregulation of IRF4 Proteinexpression Influenced by SNP Expression,

Michaela Patz, PhD, Nina-Felizitas Linde, Lukas P. Frenzel, MD, Christian P. Pallasch, MD, Reinhild Brinker, Julia Claasen, Michael Hallek, MD, Clemens Wendtner, MD

Blood (2011) 118 (21): 3886.

https://doi.org/10.1182/blood.V118.21.3886.3886

Published: 2011

Journal Articles

Novel X-Linked Inhibitor of Apoptosis (XIAP) Inhibiting Compound as Sensitizer for TRAIL-Mediated Apoptosis In Chronic Lymphocytic Leukemia with Poor Prognosis

Lukas P. Frenzel, MD, Michaela Patz, PhD, Christian P. Pallasch, MD, Reinhild Brinker, Julia Claasen, Alexandra Schulz, Michael Hallek, MD, Hamid Kashkar, PhD, Clemens-Martin Wendtner, MD

Blood (2010) 116 (21): 1375.

https://doi.org/10.1182/blood.V116.21.1375.1375

Published: 2010

Journal Articles

Depletion of Chronic Lymphocytic Leukemia Cells From Whole Blood Samples Mediated by the Anti-CD20 Antibodies Rituximab and GA101.

Michaela Patz, Nche Forcob, Bianka Müller, Christian Klein, Pablo Umana, Michael Hallek, MD, Günter Krause

Blood (2009) 114 (22): 2365.

https://doi.org/10.1182/blood.V114.22.2365.2365

Published: 2009

Journal Articles

Deregulation of miRNAs by Epigenetic Silencing Disrupts Suppression of the Oncogene PLAG1 in Chronic Lymphocytic Leukemia.

Christian P Pallasch, MD, Michaela Patz, PhD, Yoon Jung Park, PhD, Susanne Hagist, MD, Daniela Eggle, PhD, Rainer Claus, MD, Svenja Debey-Pascher, PhD, Alexandra Schulz, Lukas P Frenzel, MD, Julia Claasen, Nadine Kutsch, Günter Krause, PhD, Christine Mayr, MD, Andreas Rosenwald, MD, Christoph Plass, PhD, Joachim L Schultze, MD, Michael Hallek, MD, Clemens-Martin Wendtner, MD

Blood (2009) 114 (22): 3463.

https://doi.org/10.1182/blood.V114.22.3463.3463

Published: 2009

Journal Articles

miRNA deregulation by epigenetic silencing disrupts suppression of the oncogene PLAG1 in chronic lymphocytic leukemia

Christian Philipp Pallasch, Michaela Patz, Yoon Jung Park, Susanne Hagist, Daniela Eggle, Rainer Claus, Svenja Debey-Pascher, Alexandra Schulz, Lukas P. Frenzel, Julia Claasen, Nadine Kutsch, Günter Krause, Christine Mayr, Andreas Rosenwald, Christoph Plass, Joachim L. Schultze, Michael Hallek, Clemens-Martin Wendtner

Blood (2009) 114 (15): 3255–3264.

https://doi.org/10.1182/blood-2009-06-229898

Published: 2009

Includes: Supplemental data

Journal Articles

Deregulation of Micrornas Results in Overexpression of Oncogenic Transcription Factors Involved in Pathogenesis of CLL.

Christian P Pallasch, MD, Susanne Hagist, MD, Michaela Patz, Alexandra Schulz, Svenja Debey, Daniela Eggle, Joachim L Schultze, MD, Michael Hallek, MD, Clemens-Martin Wendtner, MD

Blood (2008) 112 (11): 2075.

https://doi.org/10.1182/blood.V112.11.2075.2075

Published: 2008

Journal Articles

The kinase inhibitor dasatinib induces apoptosis in chronic lymphocytic leukemia cells in vitro with preference for a subgroup of patients with unmutated IgV H genes

Aditya Veldurthy, Michaela Patz, Susanne Hagist, Christian P. Pallasch, Clemens-Martin Wendtner, Michael Hallek, Günter Krause

Blood (2008) 112 (4): 1443–1452.

https://doi.org/10.1182/blood-2007-11-123984

Published: 2008

Includes: Supplemental data

Journal Articles

The Src-Abl Kinase Inhibitor Dasatinib (BMS-354825) Shows Anti-Proliferative and Anti-Apoptotic Effects in Chronic Lymphocytic Leukemia (CLL) Cells In Vitro .

Aditya Veldurthy, MSc, Michaela Patz, Dipl., Biol., Christian P. Pallasch, MD, Clemens M. Wendtner, MD, Michael Hallek, MD, Gunter F. Krause, PhD

Blood (2007) 110 (11): 3101.

https://doi.org/10.1182/blood.V110.11.3101.3101

Published: 2007

NARROW

High karyotypic complexity is an independent prognostic factor in patients with CLL treated with venetoclax combinations

High Karyotypic Complexity and Translocations Are Adverse Prognostic Features in Patients with Chronic Lymphocytic Leukemia without TP53 Aberrations Treated with Venetoclax-Based Time-Limited Combinations

High efficacy of venetoclax plus obinutuzumab in patients with complex karyotype and chronic lymphocytic leukemia

ROR-1 Is a Highly Discriminative Marker in Flow Cytometric Minimal Residual Disease (MRD) Detection in Chronic Lymphocytic Leukemia (CLL)

p38 MAPK Controls Sensitivity Towards BH3 Mimetics By Regulating Mcl-1 Expression of Chronic Lymphocytic Leukemia in Hypoxia and Acquired Resistance

Impact of Hypoxia As Novel Microenvironmental Factor On Drug Susceptibility of Primary CLL Cells

Novel Tyrosine Kinase Inhibitors Trigger Drug Sensitivity of Primary CLL Cells by Controlling Glucosylation of Ceramides

B-cell receptor triggers drug sensitivity of primary CLL cells by controlling glucosylation of ceramides

B Cell Receptor Stimulation of CLL Cells Leads to Upregulation of IRF4 Proteinexpression Influenced by SNP Expression,

Novel X-Linked Inhibitor of Apoptosis (XIAP) Inhibiting Compound as Sensitizer for TRAIL-Mediated Apoptosis In Chronic Lymphocytic Leukemia with Poor Prognosis

Depletion of Chronic Lymphocytic Leukemia Cells From Whole Blood Samples Mediated by the Anti-CD20 Antibodies Rituximab and GA101.

Deregulation of miRNAs by Epigenetic Silencing Disrupts Suppression of the Oncogene PLAG1 in Chronic Lymphocytic Leukemia.

miRNA deregulation by epigenetic silencing disrupts suppression of the oncogene PLAG1 in chronic lymphocytic leukemia

Deregulation of Micrornas Results in Overexpression of Oncogenic Transcription Factors Involved in Pathogenesis of CLL.

The kinase inhibitor dasatinib induces apoptosis in chronic lymphocytic leukemia cells in vitro with preference for a subgroup of patients with unmutated IgV H genes

The Src-Abl Kinase Inhibitor Dasatinib (BMS-354825) Shows Anti-Proliferative and Anti-Apoptotic Effects in Chronic Lymphocytic Leukemia (CLL) Cells In Vitro .

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only